Contact Lenses/Eye Wear News

Myopia. Perhaps no other ocular malady – at least in the public’s eye – is more synonymous with optometry, and for good reason. For millions of people worldwide every day, a few clicks of the phoropter is a life-enhancing, if not life-altering, experience. In fact, for some of our colleagues, developing myopia as a child and remembering vividly their first eye examination is the very reason they became an optometrist. The simple act of correcting myopia is powerful and gratifying for patient and optometrist alike. Quite simply, it is an act that never gets old.

As one of the most common eye disorders around the world, myopia has dramatically increased in prevalence throughout the years, starting at younger ages than ever before.

X-Cel Specialty Contacts announced a new lens, Extreme H20 Daily, a 1-day disposable contact lens available in three diameter options, according to a press release from the company.

Model silicone hydrogel materials prepared with atropine and roscovitine to treat myopia and retinoblastoma may eliminate the need for regular drop instillation and allow for the drug concentration to be maintained in the tear film, according to Lasowski and colleagues in Optometry and Vision Science.

On Feb. 24, Prevent Blindness declared March Workplace Eye Wellness Month.

Modern high Dk miniscleral contact lenses do not cause clinically significant corneal edema after 8 hours of lens wear in young healthy participants with normal corneas, according to research in Optometry and Vision Science.

Orthokeratology is a safe option for myopia correction and retardation requiring proper lens fitting, rigorous compliance to lens care regimen, good adherence to routine follow-ups and timely treatment of complications, according to researchers in Eye and Contact Lens.

Peter Menziuso was named president, North America, Johnson & Johnson Vision Care Inc.

ATLANTA – An Alcon executive explained the company’s plans to separate its medical device and pharmaceutical businesses, during a company-sponsored press conference here at SECO.

ATLANTA – Alcon’s partnership with Google to develop wearable and implantable smart devices to assist with chronic disease management is progressing in the areas of contact lenses and IOLs, the company announced at a press conference here at SECO.